PH12016502468A1 - Influenza virus vaccines and uses thereof - Google Patents
Influenza virus vaccines and uses thereofInfo
- Publication number
- PH12016502468A1 PH12016502468A1 PH12016502468A PH12016502468A PH12016502468A1 PH 12016502468 A1 PH12016502468 A1 PH 12016502468A1 PH 12016502468 A PH12016502468 A PH 12016502468A PH 12016502468 A PH12016502468 A PH 12016502468A PH 12016502468 A1 PH12016502468 A1 PH 12016502468A1
- Authority
- PH
- Philippines
- Prior art keywords
- influenza virus
- virus vaccines
- methods
- same
- influenza
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/11—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16123—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP14176459 | 2014-07-10 | ||
US201462062754P | 2014-10-10 | 2014-10-10 | |
EP14195143 | 2014-11-27 | ||
EP15155761 | 2015-02-19 | ||
PCT/EP2015/065663 WO2016005482A1 (en) | 2014-07-10 | 2015-07-09 | Influenza virus vaccines and uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
PH12016502468A1 true PH12016502468A1 (en) | 2017-04-10 |
PH12016502468B1 PH12016502468B1 (en) | 2017-04-10 |
Family
ID=55063616
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH12016502468A PH12016502468B1 (en) | 2014-07-10 | 2016-12-12 | Influenza virus vaccines and uses thereof |
Country Status (17)
Country | Link |
---|---|
US (1) | US10117925B2 (zh) |
EP (1) | EP3166963B1 (zh) |
JP (1) | JP7094103B2 (zh) |
KR (1) | KR102463632B1 (zh) |
CN (1) | CN107074912B (zh) |
AU (1) | AU2015286723B2 (zh) |
BR (1) | BR112016030577A8 (zh) |
CA (1) | CA2953451C (zh) |
CL (1) | CL2017000064A1 (zh) |
EA (1) | EA035375B1 (zh) |
MX (1) | MX2017000395A (zh) |
MY (1) | MY182440A (zh) |
PE (1) | PE20170291A1 (zh) |
PH (1) | PH12016502468B1 (zh) |
SG (1) | SG11201610456UA (zh) |
WO (1) | WO2016005482A1 (zh) |
ZA (1) | ZA201700165B (zh) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010117786A1 (en) | 2009-03-30 | 2010-10-14 | Mount Sinai School Of Medicine Of New York University | Influenza virus vaccines and uses thereof |
CA2857087C (en) | 2011-11-28 | 2021-05-25 | Crucell Holland B.V. | Influenza virus vaccines and uses thereof |
JP2016508133A (ja) | 2012-12-18 | 2016-03-17 | アイカーン スクール オブ メディシン アット マウント サイナイ | インフルエンザウイルスワクチン及びその使用 |
WO2014159960A1 (en) | 2013-03-14 | 2014-10-02 | Icahn School Of Medicine At Mount Sinai | Antibodies against influenza virus hemagglutinin and uses thereof |
WO2014191435A1 (en) | 2013-05-30 | 2014-12-04 | Crucell Holland B.V. | Influenza virus vaccines and uses thereof |
AU2015286721B2 (en) | 2014-07-10 | 2019-11-21 | Janssen Vaccines & Prevention B.V. | Influenza virus vaccines and uses thereof |
JP2018504412A (ja) | 2015-01-23 | 2018-02-15 | アイカーン スクール オブ メディシン アット マウント サイナイ | インフルエンザウイルスワクチン接種レジメン |
CA3023143A1 (en) | 2016-06-15 | 2017-12-21 | Icahn School Of Medicine At Mount Sinai | Influenza virus hemagglutinin proteins and uses thereof |
EP3506938A1 (en) | 2016-09-02 | 2019-07-10 | The U.S.A. as represented by the Secretary, Department of Health and Human Services | Stabilized group 2 influenza hemagglutinin stem region trimers and uses thereof |
WO2018187706A2 (en) | 2017-04-07 | 2018-10-11 | Icahn School Of Medicine At Mount Sinai | Anti-influenza b virus neuraminidase antibodies and uses thereof |
CN107765001B (zh) * | 2017-10-24 | 2020-03-27 | 中国科学院苏州纳米技术与纳米仿生研究所 | 禽流感病毒感染或禽流感疫苗免疫分型试剂盒 |
SG11202006399VA (en) | 2018-01-23 | 2020-08-28 | Janssen Vaccines & Prevention Bv | Influenza virus vaccines and uses thereof |
US11576964B2 (en) * | 2018-03-28 | 2023-02-14 | Sanofi Pasteur Inc. | Methods of generating broadly protective vaccine compositions comprising hemagglutinin |
CN109239355B (zh) * | 2018-09-05 | 2020-08-25 | 中牧实业股份有限公司 | 禽流感病毒h9亚型抗体酶联免疫检测试剂盒 |
BR112021005255A2 (pt) * | 2018-09-21 | 2021-06-29 | Board Of Regents Of The University Of Nebraska | método de produção e uso de genes para vacina contra a influenza centralizada universal |
CA3152957A1 (en) * | 2019-09-05 | 2021-03-11 | Janssen Vaccines & Prevention B.V. | Influenza virus vaccines and uses thereof |
GB202004825D0 (en) * | 2020-04-01 | 2020-05-13 | Diosynvax Ltd | Influenza vaccines |
BR112023004123A2 (pt) * | 2020-09-07 | 2023-04-04 | Intervet Int Bv | Vacina de haste da ha para alvos positivos de anticorpos de ha |
TW202317600A (zh) * | 2021-06-23 | 2023-05-01 | 潤惠生技股份有限公司 | 預防多種病毒感染的多價疫苗 |
WO2023154821A2 (en) * | 2022-02-11 | 2023-08-17 | University Of Washington | Compositions comprising influenza hemagglutinin stem and method for enhancing cross-protective immunity |
WO2023198815A1 (en) | 2022-04-14 | 2023-10-19 | Janssen Vaccines & Prevention B.V. | Sequential administration of adenoviruses |
CN116589566A (zh) * | 2022-11-18 | 2023-08-15 | 昆明医科大学第一附属医院 | 一种HIV-1中和抗体的改造重组单克隆IgM抗体及其应用 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA017203B1 (ru) | 2006-09-07 | 2012-10-30 | Круселл Холланд Б.В. | Связывающие молекулы человека, способные нейтрализовать вирус гриппа h5n1, и их применение |
WO2010117786A1 (en) * | 2009-03-30 | 2010-10-14 | Mount Sinai School Of Medicine Of New York University | Influenza virus vaccines and uses thereof |
NZ596032A (en) | 2009-05-11 | 2013-09-27 | Crucell Holland Bv | Human binding molecules capable of neutralizing influenza virus h3n2 and uses thereof |
AU2011235220B2 (en) * | 2010-03-30 | 2016-03-10 | Mount Sinai School Of Medicine | Influenza virus vaccines and uses thereof |
US8900585B2 (en) * | 2010-10-20 | 2014-12-02 | New York Blood Center, Inc. | Influenza hemagglutinin-specific monoclonal antibodies for preventing and treating influenza virus infection |
WO2013007770A1 (en) | 2011-07-14 | 2013-01-17 | Crucell Holland B.V. | Human binding molecules capable of neutralizing influenza a viruses of phylogenetic group 1 and phylogenetic group 2 and influenza b viruses |
CA2857087C (en) * | 2011-11-28 | 2021-05-25 | Crucell Holland B.V. | Influenza virus vaccines and uses thereof |
WO2014191435A1 (en) * | 2013-05-30 | 2014-12-04 | Crucell Holland B.V. | Influenza virus vaccines and uses thereof |
AU2015286721B2 (en) | 2014-07-10 | 2019-11-21 | Janssen Vaccines & Prevention B.V. | Influenza virus vaccines and uses thereof |
-
2015
- 2015-07-09 MY MYPI2017700047A patent/MY182440A/en unknown
- 2015-07-09 PE PE2017000043A patent/PE20170291A1/es unknown
- 2015-07-09 CA CA2953451A patent/CA2953451C/en active Active
- 2015-07-09 KR KR1020177003528A patent/KR102463632B1/ko active IP Right Grant
- 2015-07-09 MX MX2017000395A patent/MX2017000395A/es unknown
- 2015-07-09 WO PCT/EP2015/065663 patent/WO2016005482A1/en active Application Filing
- 2015-07-09 BR BR112016030577A patent/BR112016030577A8/pt active Search and Examination
- 2015-07-09 JP JP2017500875A patent/JP7094103B2/ja active Active
- 2015-07-09 EA EA201692467A patent/EA035375B1/ru not_active IP Right Cessation
- 2015-07-09 SG SG11201610456UA patent/SG11201610456UA/en unknown
- 2015-07-09 AU AU2015286723A patent/AU2015286723B2/en active Active
- 2015-07-09 EP EP15738028.8A patent/EP3166963B1/en active Active
- 2015-07-09 CN CN201580037387.0A patent/CN107074912B/zh active Active
- 2015-07-09 US US15/324,939 patent/US10117925B2/en active Active
-
2016
- 2016-12-12 PH PH12016502468A patent/PH12016502468B1/en unknown
-
2017
- 2017-01-09 ZA ZA2017/00165A patent/ZA201700165B/en unknown
- 2017-01-10 CL CL2017000064A patent/CL2017000064A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
JP2017521073A (ja) | 2017-08-03 |
CA2953451C (en) | 2023-09-19 |
US20170189519A1 (en) | 2017-07-06 |
BR112016030577A2 (pt) | 2017-10-31 |
EP3166963A1 (en) | 2017-05-17 |
MY182440A (en) | 2021-01-25 |
US10117925B2 (en) | 2018-11-06 |
ZA201700165B (en) | 2019-06-26 |
WO2016005482A1 (en) | 2016-01-14 |
CA2953451A1 (en) | 2016-01-14 |
KR102463632B1 (ko) | 2022-11-03 |
EA035375B1 (ru) | 2020-06-03 |
EP3166963B1 (en) | 2020-04-22 |
CL2017000064A1 (es) | 2017-11-10 |
PH12016502468B1 (en) | 2017-04-10 |
KR20170027846A (ko) | 2017-03-10 |
JP7094103B2 (ja) | 2022-07-01 |
SG11201610456UA (en) | 2017-01-27 |
AU2015286723B2 (en) | 2019-11-21 |
BR112016030577A8 (pt) | 2021-07-20 |
CN107074912A (zh) | 2017-08-18 |
AU2015286723A1 (en) | 2017-01-12 |
CN107074912B (zh) | 2021-10-29 |
PE20170291A1 (es) | 2017-03-26 |
MX2017000395A (es) | 2018-02-08 |
EA201692467A1 (ru) | 2017-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12016502468A1 (en) | Influenza virus vaccines and uses thereof | |
PH12016502500A1 (en) | Influenza virus vaccines and uses thereof | |
IL247309A0 (en) | Preparations for inhibiting virus replication and methods for their preparation and use | |
PH12016501873A1 (en) | Anti-influenza b virus hemagglutinin antibodies and methods of use | |
IL286265A (en) | A new tilapia virus and its uses | |
MX2021001053A (es) | Vacunas contra virus de la influenza y sus usos. | |
IL284242A (en) | Gingerpine lysine suppressants, preparations containing them and their uses | |
EA201790517A1 (ru) | Способы и композиции для индуцирования защитного иммунитета против филовирусной инфекции | |
WO2016007540A3 (en) | Compositions and methods for treating dengue virus infection | |
WO2014152946A3 (en) | Polypeptides for treating and/or limiting influenza infection | |
MX2018014955A (es) | Vacunas atenuadas vivas del virus de la influenza equina. | |
IL246643A0 (en) | Preparations and kits for the treatment of immunodeficiency virus/acquired immunodeficiency syndrome | |
EP3236997A4 (en) | Dengue virus vaccine compositions and methods of use thereof | |
MX2017003949A (es) | Derivados peptidicos novedosos y sus usos. | |
ZA201700164B (en) | Influenza virus vaccines and uses thereof | |
IL249705B (en) | Influenza virus vaccines and their uses | |
TH1601001266A (th) | วิธีการและองค์ประกอบทางเภสัชกรรมสำหรับการบำบัดการติดเชื้อไวรัสตับอักเสบ b | |
TR201402220A2 (tr) | Hemaglütinin esteraz baskılama niteliği sergileyen pikroretosit türevlerini ihtiva eden bir kompozisyon ve bu kompozisyonun viral enfeksiyonların tedavisinde kullanımı. |